About Asterand Bioscience
Asterand Bioscience is a company based in Detroit (United States) founded in 2000 was acquired by BioIVT in August 2017.. Asterand Bioscience has raised $7.11 million across 4 funding rounds from investors including Gov.uk, BioIVT and Stemgent. Asterand Bioscience operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Detroit, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Asterand Bioscience
Asterand Bioscience has successfully raised a total of $7.11M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(21 Nov 2003)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2014 | Amount | Grant - Asterand Bioscience | Valuation |
investors |
|
| Jun, 2008 | Amount | Series D - Asterand Bioscience | Valuation |
investors |
|
| Aug, 2005 | Amount | Series D - Asterand Bioscience | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Asterand Bioscience
Asterand Bioscience has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, BioIVT and Stemgent. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm making investment in early & growth stage healthcare & tech companies in the US
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on life sciences investments.
|
Founded Year | Domain | Location | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Asterand Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Asterand Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Asterand Bioscience Comparisons
Competitors of Asterand Bioscience
Asterand Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Asterand Bioscience
Frequently Asked Questions about Asterand Bioscience
When was Asterand Bioscience founded?
Asterand Bioscience was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Where is Asterand Bioscience located?
Asterand Bioscience is headquartered in Detroit, United States. It is registered at Detroit, Michigan, United States.
Is Asterand Bioscience a funded company?
Asterand Bioscience is a funded company, having raised a total of $7.11M across 4 funding rounds to date. The company's 1st funding round was a Series D of $3.5M, raised on Nov 21, 2003.
What does Asterand Bioscience do?
Asterand was formed in 2006 through the merger of Asterand (founded 2000), a human tissue biorepository and Pharmagene (founded 1996) a human tissue-based drug discovery company. With this background and capability in human tissue procurement, characterization and research tools, Asterand Bioscience is the leading global provider of high quality, well characterized human tissue and human tissue-based research solutions to drug discovery scientists. The companys XpressBANK biobank contains several hundred thousand specimens from a broad range of therapeutic areas and with diverse ethnic representation. Through its BioSPOKE service, human tissues and clinical data can also be custom collected to meet special requirements. Through its PhaseZERO drug discovery services platform, they provide a collaborative scientific approach to deliver human tissue-based data on target biomarker validation as well as compound potency, effect and safety. The studies can be custom designed and are conducted on a fee-for-service basis where clients own and retain all resulting IP and data.
Who are the top competitors of Asterand Bioscience?
Asterand Bioscience's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Asterand Bioscience's investors?
Asterand Bioscience has 8 investors. Key investors include Gov.uk, BioIVT, Stemgent, Chrysalis Ventures, and Apjohn Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.